AB-1015

· Arsenal Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AB-1015, covering 2025-07-30 to 2025-07-30. Get the full timeline:

Most recent: Clinical Trial Update: AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer [Phase 1]

See pricing